Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 3
2014 2
2015 2
2016 1
2018 1
2019 1
2020 2
2021 4
2022 3
2023 2
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.
Chelushkin MA, van Dorp J, van Wilpe S, Seignette IM, Mellema JJ, Alkemade M, Gil-Jimenez A, Peters D, Brugman W, Stockem CF, Hooijberg E, Broeks A, van Rhijn BWG, Mertens LS, van der Heijden AG, Mehra N, van Montfoort ML, Wessels LFA, Vis DJ, van der Heijden MS. Chelushkin MA, et al. Among authors: van montfoort ml. Clin Cancer Res. 2024 Sep 13;30(18):4227-4239. doi: 10.1158/1078-0432.CCR-24-0724. Clin Cancer Res. 2024. PMID: 39047168
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study.
Downes MR, Lajkosz K, Algaba F, Allory Y, Amin MB, Cheng L, Desai S, Eckstein M, Hartmann A, Lopez-Beltran A, Mannweiler S, van Montfoort ML, Oxley J, Paner GP, Samaratunga H, Shen S, Warrick J, Williamson SR, Wobker SE, van der Kwast TH. Downes MR, et al. Among authors: van montfoort ml. Histopathology. 2025 Mar 9. doi: 10.1111/his.15438. Online ahead of print. Histopathology. 2025. PMID: 40058790
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.
Stockem CF, Gil-Jimenez A, Ali H, van Dorp J, van Dijk N, van Montfoort ML, Alkemade M, Broeks A, Seignette IM, Hooijberg E, Brugman W, Voogd R, van Rhijn BWG, Mertens LS, de Feijter JM, Mehra N, van der Heijden AG, Meijer RP, Suelmann BBM, Scheper W, Wessels LFA, Vis DJ, van der Heijden MS. Stockem CF, et al. Among authors: van montfoort ml. Clin Cancer Res. 2025 Sep 15;31(18):3897-3906. doi: 10.1158/1078-0432.CCR-25-0419. Clin Cancer Res. 2025. PMID: 40489082 Clinical Trial.
Prospective clinical study of sentinel node detection in bladder cancer using a hybrid tracer - Towards replacement of pelvic lymph node dissection in cases with sentinel node visualization on SPECT/CT?
van Gennep EJ, Pisano G, KleinJan GH, Rietbergen DDD, Hendricksen K, Mertens LS, Vd Kamp MW, Wit EMK, van Montfoort ML, Donswijk M, van Rhijn BWG, van Leeuwen FWB, van der Poel HG. van Gennep EJ, et al. Among authors: van montfoort ml. Eur J Nucl Med Mol Imaging. 2025 Aug;52(10):3653-3661. doi: 10.1007/s00259-025-07240-z. Epub 2025 Apr 4. Eur J Nucl Med Mol Imaging. 2025. PMID: 40183956 Free PMC article. Clinical Trial.
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS. van Dorp J, et al. Among authors: van montfoort ml. Nat Med. 2023 Mar;29(3):588-592. doi: 10.1038/s41591-022-02199-y. Epub 2023 Feb 2. Nat Med. 2023. PMID: 36732628 Clinical Trial.
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
Einerhand SMH, van Dijk N, van Dorp J, de Feijter JM, van Montfoort ML, van de Kamp MW, Schaake EE, Boellaard TN, Hendricksen K, van der Heijden MS, van Rhijn BWG. Einerhand SMH, et al. Among authors: van montfoort ml. Int J Cancer. 2022 Dec 1;151(11):2004-2011. doi: 10.1002/ijc.34125. Epub 2022 Jun 10. Int J Cancer. 2022. PMID: 35603905 Clinical Trial.
A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer.
van Dorp J, van Montfoort ML, van Dijk N, Hofland I, de Feijter JM, Bergman AM, Hendricksen K, van der Poel HG, van Rhijn BWG, van der Heijden MS. van Dorp J, et al. Among authors: van montfoort ml. Clin Genitourin Cancer. 2022 Apr;20(2):e173-e179. doi: 10.1016/j.clgc.2021.12.004. Epub 2021 Dec 10. Clin Genitourin Cancer. 2022. PMID: 35016887 No abstract available.
The dynamics of HER2 status in esophageal adenocarcinoma.
Creemers A, Ebbing EA, Hooijer GKJ, Stap L, Jibodh-Mulder RA, Gisbertz SS, van Berge Henegouwen MI, van Montfoort ML, Hulshof MCCM, Krishnadath KK, van Oijen MGH, Bijlsma MF, Meijer SL, van Laarhoven HWM. Creemers A, et al. Among authors: van montfoort ml. Oncotarget. 2018 Jun 1;9(42):26787-26799. doi: 10.18632/oncotarget.25507. eCollection 2018 Jun 1. Oncotarget. 2018. PMID: 29928485 Free PMC article.
27 results